Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * Disallow: /tilda/form* Disallow: /tilda/rec* Disallow: /tilda/click* Disallow: /tilda/scroll* Disallow: /tilda/popup* Disallow: /tilda/cart* Disallow: /tilda/product* Disallow: /tilda/event* Disallow: /*_escaped_fragment_* Disallow: Sitemap: https://insubiq.com/sitemap.xml Host: |
Title | Cough Detection |
Description | How it Cough Detection App for clinical |
Keywords | N/A |
WebSite | insubiq.com |
Host IP | 185.215.4.24 |
Location | - |
Site | Rank |
US$1,737
Last updated: 2023-05-20 04:12:54
insubiq.com has Semrush global rank of 0. insubiq.com has an estimated worth of US$ 1,737, based on its estimated Ads revenue. insubiq.com receives approximately 200 unique visitors each day. Its web server is located in -, with IP address 185.215.4.24. According to SiteAdvisor, insubiq.com is safe to visit. |
Purchase/Sale Value | US$1,737 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$48 |
Yearly Ads Revenue | US$577 |
Daily Unique Visitors | 13 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
insubiq.com. | A | 300 | IP: 185.215.4.24 |
insubiq.com. | NS | 86400 | NS Record: ns-373.awsdns-46.com. |
insubiq.com. | NS | 86400 | NS Record: ns-816.awsdns-38.net. |
insubiq.com. | NS | 86400 | NS Record: ns-1324.awsdns-37.org. |
insubiq.com. | NS | 86400 | NS Record: ns-1960.awsdns-53.co.uk. |
insubiq.com. | MX | 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
insubiq.com. | MX | 3600 | MX Record: 1 aspmx.l.google.com. |
insubiq.com. | MX | 3600 | MX Record: 10 alt3.aspmx.l.google.com. |
insubiq.com. | MX | 3600 | MX Record: 10 alt4.aspmx.l.google.com. |
insubiq.com. | MX | 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
Validation Study Book a demo An average of over 3,500 clinical trials take place in the respiratory space each year 1 Cough is a symptom of asthma, COPD, IPF, cystic fibrosis, heart failure, COVID-19, and many other diseases In clinical trials, endpoints aimed at disease burden on patient’s life, often document information through questionnaires Daily cough, and especially night cough, could be under-reported in this context Current issues facing respiratory-related clinical trials Cough frequency is a key factor in respiratory disease evolution or drug response analysis. Daily cough, and especially night cough , could be under-reported if participants document information through questionnaires. 90% Market 9 out of the 10 top pharma are in respiratory, with the global market for respiratory drugs valued at $90B 1 1.9% ROI crisis New drug research and development (R&D) investments by top pharma firms fell to 1.9%, from 10.1% in 2010 (Deloitte) 2 26% Recruiting of respiratory trials |
HTTP/1.1 301 Moved Permanently Server: ddos-guard Connection: keep-alive Keep-Alive: timeout=60 Set-Cookie: __ddg1_=gImkH25FNOAwTorQodSN; Domain=.insubiq.com; HttpOnly; Path=/; Expires=Sat, 06-Jan-2024 09:16:37 GMT Date: Fri, 06 Jan 2023 09:16:37 GMT Content-Type: text/html; charset=iso-8859-1 Content-Length: 228 Location: https://insubiq.com/ X-Host: insubiq.com cache-control: max-age=0 cache-control: public HTTP/2 200 server: ddos-guard set-cookie: __ddg1_=y9Wquc7jk8eJTXS7sgME; Domain=.insubiq.com; HttpOnly; Path=/; Expires=Sat, 06-Jan-2024 09:16:37 GMT date: Fri, 06 Jan 2023 09:16:37 GMT content-type: text/html; charset=UTF-8 content-length: 211085 last-modified: Thu, 07 Apr 2022 15:14:44 GMT etag: "3388d-5dc11f0220886" vary: Accept-Encoding x-frame-options: SAMEORIGIN x-host: insubiq.com cache-control: max-age=0 cache-control: public accept-ranges: bytes |